The China National Medical Products Association (NMPA) has approved Shingrix for the prevention of shingles. Shingrix has been approved for the prevention of virus in adults aged 18 years and over who are at increased risk of shingles due to immunodeficiency or immunosuppression. Shingles is caused by the reactivation of the varicella zoster virus (VZV), […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!
